Blood pressure and allergy medication interact in ways that matter greatly for the millions of people in the UK managing both conditions. Certain allergy treatments — particularly oral decongestants such as pseudoephedrine — can raise blood pressure, counteract antihypertensive therapy, and in rare cases cause serious cardiovascular events. Antihistamines and intranasal corticosteroids generally carry a more favourable safety profile, but individual circumstances vary. This article explains which allergy medications are safest for people with hypertension, which combinations to avoid, and when to seek advice from a GP or pharmacist.

How Allergy Medications Can Affect Blood Pressure

Oral decongestants such as pseudoephedrine raise blood pressure through vasoconstriction and are contraindicated in severe or uncontrolled hypertension; antihistamines and intranasal corticosteroids carry a much lower cardiovascular risk.

For people managing both allergies and hypertension, understanding how allergy medications interact with blood pressure is an important aspect of safe self-care. Several classes of allergy medication — including antihistamines, decongestants, and corticosteroid nasal sprays — can influence cardiovascular function to varying degrees, and some carry a more significant risk than others.

Worried about interactions with other medications? Speak to one of our pharmacists →

Decongestants are among the most clinically relevant in this context. Medications such as pseudoephedrine and phenylephrine work by causing vasoconstriction — narrowing of the blood vessels — to reduce nasal congestion. This same mechanism can raise systemic blood pressure and increase heart rate. For pseudoephedrine, this effect is well established; for oral phenylephrine, the evidence of a meaningful rise in blood pressure at standard over-the-counter (OTC) doses is more variable, though product SmPCs (Summaries of Product Characteristics) still advise caution in people with hypertension. Oral decongestants should be avoided in severe or uncontrolled hypertension and used only with caution — and ideally under medical supervision — in those with controlled hypertension.

Importantly, the MHRA has issued safety advice that pseudoephedrine is associated with a rare but serious risk of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS). It is contraindicated in people with severe or uncontrolled hypertension. Patients should stop taking pseudoephedrine and seek urgent medical attention if they develop a sudden severe headache, confusion, visual disturbances, or seizures.

Antihistamines, by contrast, generally have a more modest effect on blood pressure. Intranasal corticosteroids such as fluticasone or mometasone are considered low-risk for blood pressure effects when used at recommended doses, as systemic absorption is minimal; individual product SmPCs should be consulted for specific warnings. Understanding these distinctions helps patients and clinicians make informed choices about allergy management without compromising cardiovascular safety.

For further information, see the NHS guidance on who can and cannot take decongestants, and the relevant EMC SmPCs for pseudoephedrine- and phenylephrine-containing products.

Antihistamines and Decongestants: What the Evidence Shows

Second-generation antihistamines (cetirizine, loratadine, fexofenadine) are generally safe in hypertension, while oral pseudoephedrine can raise systolic blood pressure and should be used with caution or avoided in people with high blood pressure.

Antihistamines are broadly divided into first-generation (sedating) and second-generation (non-sedating) agents. First-generation antihistamines such as chlorphenamine can cause anticholinergic effects — including dry mouth, urinary retention, and mild tachycardia — which may be relevant in patients with pre-existing cardiovascular conditions. Second-generation antihistamines, including cetirizine, loratadine, and fexofenadine, are generally better tolerated and have a more favourable cardiovascular safety profile. Loratadine and fexofenadine, in particular, are widely considered safe for most people with hypertension when used at standard doses in accordance with the BNF and product labelling.

Decongestants present a more significant concern. Both oral and topical decongestants (such as xylometazoline nasal sprays) stimulate alpha-adrenergic receptors, leading to vasoconstriction. Clinical evidence, including a systematic review by Salerno et al. (2005), indicates that oral pseudoephedrine can raise systolic blood pressure by an average of approximately 1–3 mmHg in healthy individuals, with potentially greater effects in those with hypertension or those taking antihypertensive medications; these findings were largely from short-term studies in controlled or healthy populations. The evidence for a clinically meaningful blood pressure rise with oral phenylephrine at standard OTC doses is less consistent, though SmPC cautions for people with hypertension remain in place. The NHS advises that decongestants may not be suitable for people with high blood pressure.

Topical nasal decongestants such as xylometazoline (e.g., Otrivine) should be limited to a maximum of seven consecutive days to avoid rebound congestion (rhinitis medicamentosa), as stated in the product SmPC.

It is also worth noting that some OTC combination cold and allergy remedies contain both an antihistamine and a decongestant. Patients with high blood pressure should check product labels carefully or consult a pharmacist before purchasing these products, as the decongestant component may not be immediately obvious from the brand name alone.

Still have questions? Message our pharmacists for free →

Medications and Combinations to Use With Caution

Oral decongestants, non-selective beta-blocker and decongestant combinations, NSAIDs alongside antihypertensives, and certain herbal remedies all warrant caution due to their potential to raise blood pressure or reduce antihypertensive efficacy.

Certain allergy medications and drug combinations warrant particular caution in the context of blood pressure management. The following are key considerations:

• Oral decongestants (pseudoephedrine, phenylephrine): These should be avoided in severe or uncontrolled hypertension and used only under medical supervision in those with controlled hypertension, ischaemic heart disease, or those taking monoamine oxidase inhibitors (MAOIs). The vasoconstrictive effect can counteract antihypertensive therapy. See BNF: Sympathomimetics for interaction guidance.

• First-generation antihistamines used alongside antihypertensives: The primary concern with sedating antihistamines such as chlorphenamine is additive sedation, which increases the risk of dizziness and falls — particularly in older adults. This is not a consistent pharmacodynamic hypotensive interaction, but the sedation and impaired balance it causes can be clinically significant.

• Non-steroidal anti-inflammatory drugs (NSAIDs) used alongside allergy treatment: While not allergy medications themselves, NSAIDs such as ibuprofen are sometimes taken concurrently for allergy-related symptoms. NSAIDs can raise blood pressure and reduce the efficacy of antihypertensives, including ACE inhibitors, angiotensin receptor blockers (ARBs), and diuretics. NICE NG136 (Hypertension in adults) highlights the need for monitoring when NSAIDs are used in people with hypertension. The combination of an ACE inhibitor or ARB with a diuretic and an NSAID (sometimes called the 'triple whammy') also carries a risk of acute kidney injury and should be avoided where possible.

• Beta-blockers and decongestants: In people taking non-selective beta-blockers, sympathomimetic decongestants can cause a rise in blood pressure due to unopposed alpha-adrenergic vasoconstriction. This interaction is noted in the BNF under sympathomimetics.

• Herbal remedies: Some herbal products marketed for allergy relief — such as those containing liquorice root — can raise blood pressure and interact with prescribed medications. Ephedra-containing products are not permitted for sale in the UK. Many herbal products are not licensed medicines; those with a Traditional Herbal Registration (THR) mark have met MHRA quality and safety standards, but this does not guarantee freedom from interactions. Patients should disclose all herbal and supplement use to their GP or pharmacist.

Always review the full medication list before adding any new allergy treatment.

When to Seek Advice From a GP or Pharmacist

Seek urgent medical attention if pseudoephedrine causes a sudden severe headache, confusion, or visual disturbances; consult a pharmacist or GP before starting any new allergy medication if you have hypertension or take antihypertensive drugs.

Many allergy medications are available without prescription, which can give the impression that they are universally safe. However, for individuals with hypertension or other cardiovascular conditions, professional guidance before starting a new allergy treatment is strongly advisable. A pharmacist is an accessible first point of contact and can review your current medications, check for interactions, and recommend the most appropriate OTC option.

Call 999 immediately if you experience chest pain, severe breathlessness, signs of a stroke (such as facial drooping, arm weakness, or speech difficulty — think FAST), or a sudden severe 'worst-ever' headache. These may indicate a medical emergency. Call NHS 111 if you need urgent advice but it is not a life-threatening emergency.

You should seek prompt advice from a GP or pharmacist if you experience any of the following after starting an allergy medication:

• A noticeable increase in blood pressure readings at home

• Palpitations or an irregular heartbeat

• Dizziness, light-headedness, or fainting

• Worsening of symptoms despite treatment

If you are taking pseudoephedrine and develop a sudden severe headache, confusion, visual disturbances, or seizures, stop the medication immediately and seek urgent medical attention. These symptoms may indicate a rare but serious condition (PRES or RCVS) associated with pseudoephedrine use, as highlighted in MHRA safety advice.

If you are already prescribed antihypertensive medication and are unsure whether a particular allergy product is safe to take alongside it, do not assume compatibility based on OTC availability alone. The NHS recommends that patients with long-term conditions always check with a healthcare professional before adding new medications, including those bought over the counter.

In cases where allergy symptoms are severe, persistent, or significantly affecting quality of life, a GP referral to an allergy specialist may be appropriate. Specialist-led management can offer options such as allergen immunotherapy, which addresses the underlying cause rather than simply managing symptoms.

If you think you have experienced a side effect from any medication, you can report it to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk or through the Yellow Card app.

Managing Allergies Safely Alongside Blood Pressure Treatment

Second-generation antihistamines and intranasal corticosteroids are the preferred allergy treatments for people with hypertension; non-pharmacological measures such as allergen avoidance and nasal saline irrigation can also reduce the need for medication.

With careful selection of treatments, the vast majority of people with hypertension can manage their allergy symptoms effectively and safely. The key is choosing medications with a low cardiovascular risk profile and avoiding those known to interfere with blood pressure control.

Preferred options for people with hypertension include:

• Second-generation antihistamines such as cetirizine, loratadine, or fexofenadine — these are generally considered safe and are widely recommended by pharmacists for patients with high blood pressure. Dosing should follow product labelling and the BNF; dose adjustments may be required in renal or hepatic impairment for certain agents.

• Intranasal corticosteroid sprays (e.g., fluticasone, budesonide, mometasone) — these are highly effective for allergic rhinitis and carry minimal systemic absorption at standard doses, making them a preferred first-line option for moderate-to-severe or persistent symptoms, in line with NICE CKS: Allergic rhinitis and BSACI rhinitis guidance.

• Sodium cromoglicate eye drops or nasal spray — a mast cell stabiliser with a very low systemic effect, suitable for localised allergic symptoms.

If a topical nasal decongestant is considered necessary for short-term relief, it should be used for no more than seven consecutive days to prevent rebound congestion, as advised in product SmPCs (e.g., Otrivine xylometazoline nasal spray).

Non-pharmacological strategies also play an important role. Reducing allergen exposure through measures such as using allergen-proof bedding and avoiding known triggers can meaningfully reduce the need for medication. Nasal saline irrigation is a safe, drug-free option that can help relieve nasal congestion without any cardiovascular risk. Air purifiers are used by some people, though the evidence for their benefit in allergic rhinitis is variable; NHS hay fever self-care guidance provides practical, evidence-based advice on reducing exposure.

Regular blood pressure monitoring at home is advisable for anyone with hypertension who is starting a new allergy treatment. If readings consistently exceed your agreed target range, discuss this with your GP promptly. Open communication between patient and healthcare provider — including disclosure of all OTC, herbal, and supplement products — remains the cornerstone of safe, effective allergy management alongside blood pressure treatment.

Frequently Asked Questions